ADC lsotype Control Human IgG1 (Exatecan)

Numéro de produit/spécification
Prix
Availability
Qté
DNP-D904P1-100ug
$195.00
In Stock - Delivery in 1-2 business days
DNP-D904P1-1mg (500ug X 2)
$790.00
In Stock - Delivery in 1-2 business days
Montant du produit:
$ 0
0
Ajouter au panier
  • Détails du produit
  • Affichage des données
  • Reviews & Citations
  • Important Statement
  • Resources
Source

ADC lsotype Control Human IgG1 (Exatecan) is recombinantly expressed in HEK293. It consists of mouse variable regions genetically fused to human IgG1 constant domains.

Antibody Type

Recombinant Monoclonal

Clone

AM1

Isotype

Human IgG1, Kappa

Host Species

Mouse

DAR

8

Purification

Protein A purified.

Aggregation

Less than 10%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

Introduction de fond

Exatecan is a semi-synthetic camptothecin-derived topoisomerase I inhibitor. It specifically binds to and inhibits topoisomerase I, blocking DNA replication and transcription processes to potently suppress tumor cell proliferation. As a highly active cytotoxic payload, it serves as a core component of multiple antibody-drug conjugates (ADCs) and is widely used in the research, development and clinical translation of targeted anti-tumor ADC drugs.

ACRO Scientific Leadership Award

Supporting the scientists driving cell & gene therapy forward

Apply Now